Irreversible Elektroporation – ein neues Therapieverfahren auf dem Prüfstand

Julian H. W. Jürgens; Uwe-Bernd Liehr; Johann J. Wendler

doi:10.1055/s-0042-101580

Interventionelle Radiologie Scan, Table of Contents

Interventionelle Radiologie Scan 2016; 04(01): 69-86
DOI: 10.1055/s-0042-101580

Fortbildung

Irreversible Elektroporation – ein neues Therapieverfahren auf dem Prüfstand

Authors

Julian H. W. Jürgens
Uwe-Bernd Liehr
Johann J. Wendler

Abstract

Full Text

References

Literatur
1 Doevenspeck H. Influencing cells and cell walls by electrostatic impulses. Fleischwirtschaft 1961; 13: 986-987
2 Davalos RV, Mir IL, Rubinsky B. Tissue ablation with irreversible electroporation. Ann Biomed Eng 2005; 33: 223-231
3 Sugar IP, Neumann E. Stochastic model for electric field-induced membrane pores. Electroporation. Biophys Chem 1984; 19: 211-225
4 Lee EW, Wong D, Prikhodko SV et al. Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes. J Vasc Interv Radiol 2012; 23: 107-113
5 Edd JF, Horowitz L, Davalos RV et al. In vivo results of a new focal tissue ablation technique: irreversible electroporation. IEEE Trans Biomed Eng 2006; 53: 1409-1415
6 Rubinsky B. Irreversible Electroporation. Berlin: Springer; 2010
7 Kosiek O, Strach K, Ricke J et al. Irreversible electroporation – a new kid on the block?. Radiologe 2012; 52: 38-43
8 Choi JW, Lu DS, Osuagwu F et al. Assessment of chronological effects of irreversible electroporation on hilar bile ducts in a porcine model. Cardiovasc Intervent Radiol 2014; 37: 224-230
9 Kasivisvanathan V, Shah TT, Donaldson I et al. Focal therapy for prostate cancer: German version. Urologe A 2015; 54: 202-209
10 Li W, Fan Q, Ji Z et al. The effects of irreversible electroporation (IRE) on nerves. PLoS One 2011; 6: e18831
11 Schoellnast H, Monette S, Ezell PC et al. Acute and subacute effects of irreversible electroporation on nerves: experimental study in a pig model. Radiology 2011; 260: 421-427
12 Schoellnast H, Monette S, Ezell PC et al. The delayed effects of irreversible electroporation ablation on nerves. Eur Radiol 2013; 23: 375-380
13 Wendler JJ, Pech M, Blaschke S et al. Angiography in the isolated perfused kidney: radiological evaluation of vascular protection in tissue ablation by nonthermal irreversible electroporation. Cardiovasc Intervent Radiol 2012; 35: 383-390
14 Wendler JJ, Pech M, Porsch M et al. Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology. Cardiovasc Intervent Radiol 2012; 35: 921-926
15 Wendler JJ, Porsch M, Huhne S et al. Short- and mid-term effects of irreversible electroporation on normal renal tissue: an animal model. Cardiovasc Intervent Radiol 2013; 36: 512-520
16 Nielsen K, Scheffer HJ, Vieveen JM et al. Anaesthetic management during open and percutaneous irreversible electroporation. Br J Anaesth 2014; 113: 985-992
17 Garcia PA, Rossmeisl Jr JH, Robertson JL et al. 7.0-T magnetic resonance imaging characterization of acute blood-brain-barrier disruption achieved with intracranial irreversible electroporation. PLoS One 2012; 7: e50482
18 Rossmeisl Jr JH, Garcia PA, Pancotto TE et al. Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas. J Neurosurg 2015; 123: 1008-1025
19 Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in “out of operating theater” anesthesia. Anesth Analg 2010; 110: 1305-1309
20 Martin RC, Schwartz E, Adams J et al. Intra-operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors. Anesth Pain Med 2015; 5: e22786
21 Arena CB, Sano MB, Rossmeisl Jr JH et al. High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online 2011; 10: 102
22 Deodhar A, Dickfeld T, Single GW et al. Irreversible electroporation near the heart: ventricular arrhythmias can be prevented with ECG synchronization. AJR Am J Roentgenol 2011; 196: W330-W335
23 Sugimoto K, Moriyasu F, Takeuchi H et al. Case study to assess the safety of irreversible electroporation near the heart. Springerplus 2015; 4: 74
24 Thomson KR, Cheung W, Ellis SJ et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol 2011; 22: 611-621
25 Ricke J, Jurgens JH, Deschamps F et al. Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial. Cardiovasc Intervent Radiol 2015; 38: 401-408
26 Fredericks C, Arslan B, Mullane M et al. Needle tract seeding following irreversible electroporation (IRE) of metastatic colorectal carcinoma to the liver. Cardiovasc Intervent Radiol 2015; 38: 1349-1351
27 Liehr UB, Wendler JJ, Blaschke S et al. Irreversible electroporation: the new generation of local ablation techniques for renal cell carcinoma. Urologe A 2012; 51: 1728-1734
28 Xiao C, Rubinsky B. Theoretical analysis of AC electric field transmission into biological tissue through frozen saline for electroporation. Bioelectromagnetics 2014; 35: 607-613
29 Golberg A, Bruinsma BG, Uygun BE et al. Tissue heterogeneity in structure and conductivity contribute to cell survival during irreversible electroporation ablation by “electric field sinks”. Sci Rep 2015; 5: 8485
30 Neal RE, Kavnoudias H, Thomson KR. An “off-the-shelf” system for intraprocedural electrical current evaluation and monitoring of irreversible electroporation therapy. Cardiovasc Intervent Radiol 2015; 38: 736-741
31 Mansson C, Nilsson A, Karlson BM. Severe complications with irreversible electroporation of the pancreas in the presence of a metallic stent: a warning of a procedure that never should be performed. Acta Radiol Short Rep 2014; 3: 2047981614556409
32 Faroja M, Ahmed M, Appelbaum L et al. Irreversible electroporation ablation: Is all the damage nonthermal?. Radiology 2013; 266: 462-470
33 van Gemert MJ, Wagstaff PG, de Bruin DM et al. Irreversible electroporation: just another form of thermal therapy?. Prostate 2015; 75: 332-335
34 Dunki-Jacobs EM, Philips P, Martin RC. Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model. Br J Surg 2014; 101: 1113-1121
35 Davalos RV, Bhonsle S, Neal RE. Implications and considerations of thermal effects when applying irreversible electroporation tissue ablation therapy. Prostate 2015; 75: 1114-1118
36 Kluger MD, Epelboym I, Schrope BA et al. Single-institution experience with irreversible electroporation for T4 pancreatic cancer: first 50 patients. Ann Surg Oncol 2015; [Epub ahead of print]
37 Little MW, Chung D, Boardman P et al. Microwave ablation of pulmonary malignancies using a novel high-energy antenna system. Cardiovasc Intervent Radiol 2013; 36: 460-465
38 Yan TD, King J, Sjarif A et al. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13: 1529-1537
39 Bilal H, Mahmood S, Rajashanker B et al. Is radiofrequency ablation more effective than stereotactic ablative radiotherapy in patients with early stage medically inoperable non-small cell lung cancer?. Interact Cardiovasc Thorac Surg 2012; 15: 258-265
40 Lee H, Jin GY, Han YM et al. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy. Cardiovasc Intervent Radiol 2012; 35: 343-350
41 Usman M, Moore W, Talati R et al. Irreversible electroporation of lung neoplasm: a case series. Med Sci Monit 2012; 18: CS43-CS47
42 Scheffer HJ, Nielsen K, van Tilborg AA et al. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study. Eur Radiol 2014; 24: 2467-2475
43 Niessen C, Igl J, Pregler B et al. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study. J Vasc Interv Radiol 2015; 26: 694-702
44 Fritz S, Sommer CM, Vollherbst D et al. Irreversible electroporation of the pancreas is feasible and safe in a porcine survival model. Pancreas 2015; 44: 791-798
45 Trueba-Arguinarena FJ, de Prado-Otero DS, Poves-Alvarez R. Pancreatic adenocarcinoma treated with irreversible electroporation case report: first experience and outcome. Medicine (Baltimore) 2015; 94: e946
46 Moir J, White SA, French JJ et al. Systematic review of irreversible electroporation in the treatment of advanced pancreatic cancer. Eur J Surg Oncol 2014; 40: 1598-1604
47 Martin RC, McFarland K, Ellis S et al. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg 2012; 215: 361-369
48 Seufferlein T, Bachet JB, Van CE et al. Pancreatic adenocarcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012; 23: vii33-vii40
49 Venkat S, Hosein PJ, Narayanan G. Percutaneous approach to irreversible electroporation of the pancreas: Miami protocol. Tech Vasc Interv Radiol 2015; 18: 153-158
50 Young SJ. Irreversible electroporation and the pancreas: What we know and where we are going?. World J Gastrointest Surg 2015; 7: 138-144
51 Ljungberg B, Bensalah K, Canfield S et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 2015; 67: 913-924
52 Pech M, Janitzky A, Wendler JJ et al. Irreversible electroporation of renal cell carcinoma: a first-in-man phase I clinical study. Cardiovasc Intervent Radiol 2011; 34: 132-138
53 Wendler JJ, Porsch M, Nitschke S et al. A prospective phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial). Contemp Clin Trials 2015; 43: 10-19
54 Wendler JJ, Ricke J, Pech M et al. First delayed resection findings after irreversible electroporation (IRE) of human localised renal cell carcinoma (RCC) in the IRENE pilot phase 2a trial. Cardiovasc Intervent Radiol 2015; [Epub ahead of print]
55 Rendon RA, Kachura JR, Sweet JM et al. The uncertainty of radio frequency treatment of renal cell carcinoma: findings at immediate and delayed nephrectomy. J Urol 2002; 167: 1587-1592
56 Klingler HC, Marberger M, Mauermann J et al. “Skipping” is still a problem with radiofrequency ablation of small renal tumours. BJU Int 2007; 99: 998-1001
57 Valerio M, Stricker PD, Ahmed HU et al. Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer. Prostate Cancer Prostatic Dis 2014; 17: 343-347
58 van den Bos W, de Bruin DM, van Randen A et al. MRI and contrast-enhanced ultrasound imaging for evaluation of focal irreversible electroporation treatment: results from a phase I–II study in patients undergoing IRE followed by radical prostatectomy. Eur Radiol 2015; [Epub ahead of print]
59 van den Bos W, de Bruin DM, Jurhill RR et al. The correlation between the electrode configuration and histopathology of irreversible electroporation ablations in prostate cancer patients. World J Urol 2015; [Epub ahead of print]
60 Tomihama RT, Günther E, Kim D et al. Irreversible electroporation treatment for prostate adenocarcinomas: a safety outcome study. J Vasc Intervent Radiol 2015; 26: 121-S122
61 Neal RE, Smith RL, Kavnoudias H et al. The effects of metallic implants on electroporation therapies: feasibility of irreversible electroporation for brachytherapy salvage. Cardiovasc Intervent Radiol 2013; 36: 1638-1645
62 Qin Z, Jiang J, Long G et al. Irreversible electroporation: an in vivo study with dorsal skin fold chamber. Ann Biomed Eng 2013; 41: 619-629
63 Phillips MA, Narayan R, Padath T et al. Irreversible electroporation on the small intestine. Br J Cancer 2012; 106: 490-495
64 Schoellnast H, Monette S, Ezell PC et al. Irreversible electroporation adjacent to the rectum: evaluation of pathological effects in a pig model. Cardiovasc Intervent Radiol 2013; 36: 213-220
65 Srimathveeravalli G, Wimmer T, Monette S et al. Evaluation of an endorectal electrode for performing focused irreversible electroporation ablations in the Swine rectum. J Vasc Interv Radiol 2013; 24: 1249-1256
66 Niessen C, Jung EM, Beyer L et al. Percutaneous irreversible electroporation (IRE) of prostate cancer: contrast-enhanced ultrasound (CEUS) findings. Clin Hemorheol Microcirc 2015; 61: 135-141
67 Ting F, Tran M, Bohm M et al. Focal irreversible electroporation for prostate cancer: functional outcomes and short-term oncological control. Prostate Cancer Prostatic Dis 2015; [Epub ahead of print]
68 Wendler JJ, Fischbach K, Ricke J et al. Irreversible electroporation (IRE): standardization of terminology and reporting criteria for analysis and comparison. Pol J Radiol 2016; [in press, Feb 2016]